A study to investigate how effective and safe the study medication ‘mirabegron’ is and how long it stays in the body in children and adolescents aged 3 to less than 18 years with symptoms of an overac...

Update Il y a 5 ans
Reference: EUCTR2015-002876-25

A study to investigate how effective and safe the study medication ‘mirabegron’ is and how long it stays in the body in children and adolescents aged 3 to less than 18 years with symptoms of an overactive bladder with a neurologic cause

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the efficacy of mirabegron after multiple-dose administration in the pediatric population.


Inclusion criteria

  • Neurogenic Detrusor Overactivity (NDO)